Xinrui Li

Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials

Q. Wei, P. Fu, Yan Yang, 2018, Chinese medical journal.

Pharmacological urate-lowering approaches in chronic kidney disease.

P. Fu, Jing Liu, Liang Ma, 2019, European journal of medicinal chemistry.

Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy

Yi Li, P. Fu, Lingzhi Li, 2020, Renal failure.

2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury

P. Fu, Jing Liu, Liang Ma, 2019, PloS one.

Research progress on the role of hormones in ischemic stroke

Xianhui Kang, Shengmei Zhu, Xinrui Li, 2022, Frontiers in Immunology.

Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis

Q. Wei, P. Fu, Yan Yang, 2018, BMC Nephrology.

Genetic inhibition of FABP4 attenuated endoplasmic reticulum stress and mitochondrial dysfunction in rhabdomyolysis-induced acute kidney injury.

Xiaoxi Zeng, P. Fu, Jing Liu, 2021, Life sciences.